Add Yahoo as a preferred source to see more of our stories on Google. acne Severe acne can be horrifically debilitating. It leaves sufferers drained of confidence, sometimes even unwilling to leave ...

A new study from researchers at Mass General Brigham examined how often, acne recurs after isotretinoin, the only approved medical treatment capable of inducing long-term remission of severe acne. The ...

If you’re someone who’s experienced recurring bouts of cystic acne, you’ll know there’s no one-size-fits-all approach to keeping acne flares at bay. Clearing your skin can feel like a bit of a waiting ...

Acne is a skin condition characterized by clogged pores. When pores get clogged, it causes red lesions — which you know as pimples — to form on the face or other areas of the body, especially those ...

PARIS — Oral treatment with the novel fatty acid synthase inhibitor denifanstat was associated with significant improvements in moderate-to-severe acne in a phase 3 trial presented at the European ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Brandi Jones has over two decades of experience as a nurse in an acute care setting. Her clinical background includes pediatrics, medical-surgical, and women's health. She also specializes in ...

Sagimet Biosciences (NASDAQ:SGMT) added ~38% in the premarket on Wednesday after the company said its Chinese licensing partner, Ascletis Bioscience, had reached all primary and secondary endpoints in ...